Thomson Reuters Corp (TRI.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Thomson Reuters Corp (TRI.TO)

147.65

+4.80 (3.36%)

as of Aug 13, 2026, 8:00:00 pm Market Open.

221 watching

Investor Insights

Aug 13, 2026, 12:00 am

This summary was created by AI, based on 37 opinions in the last 12 months.

Thomson Reuters Corp (TRI-T) is experiencing a mix of skepticism and optimism driven by fears surrounding AI's potential impact on its services, particularly in the legal and accounting sectors. Despite these concerns, many analysts believe TRI’s proprietary data and established market position provide some insulation against AI disruption. The company recently reported solid earnings growth and is investing in share buybacks, indicating confidence in its future. Several experts view the current valuation as more attractive than before and see opportunities for long-term growth, while caution still exists due to valuation discussions and market sentiment. The firm's traditional business model continues to be seen as viable, and many believe it's well-positioned to integrate AI into its offerings, potentially enhancing its competitive advantage.

Consensus

Buy

Valuation

Undervalued

Similar

TMX,TMX

DON'T BUY

Great businesses, decent margins, some real franchise operations, but the stock is still too expensive. Needs time for the cash flow generation to show on the balance sheet and pay down some of its debt.

Wealthica Track your Stocks in your Watch List

PAST TOP PICK

(A Top Pick Aug 26/04. Down 5%.) Still likes and considers it a core holding in some of the portfolios. Expects to see better returns on equity, invested capital.

PAST TOP PICK

(A Top Pick Nov 15/04. Down 2.5%.) Still likes. One of the few stocks that is nowhere near its 52 week high. Has reported a couple of decent quarters here. Would still be a buyer at this level.

HOLD

Have had to be extraordinarilly patient with the stock. Was a high multiple stock. Still likes its growth strategy, supplying data base management. May take some time.

WEAK BUY

Has always been valued at a fairly high multiple. Because of this, hasn't seen too much of a total return expectation from the company. At this level, it would be a reasonable trade, but does get expensive fairly quickly because of its valuation point and the slower growth rate.

HOLD

A company that seems to be doing most of the right things, but hasn't seen the stock move at all and creating the earnings growth. Haven't given up on it yet.

DON'T BUY

A solid company, but the problem is, it doesn't generate enough free cash flow to sustain this price. Their valuation is in the $25/30 range. Margins are stretched because pricing power is not there.

PAST TOP PICK

(A Top Pick Aug 9/04. Down 2.5%.) Still likes. An enquiry in one of their divisions by Spitzer knocked the stock back Until that is resolved, the stock will be in a holding pattern.

SELL

Dead money. Has beeen going through a transition over a number of years.

TOP PICK

Has lagged. They beat expectations and raised their guidance again last quarter. Should do it again.

BUY

Growing and doing well in their core markets. Has been overvalued, but is now at the point where it can grow at the level that its cash flows are growing. Expects a 10/12% growth.

DON'T BUY

Have some great assets. Lots of cash. To make accretive acquisitions they have to pay significant $'s.

BUY

As time goes on, expects to see them expand into more and more scientific and engineering endeavours. Good long term hold.

PAST TOP PICK

(A Top Pick Aug 9/04. Down 4%.) Disappointed with the stock performance. Would still buy at this price. Made a big turn around in the last 2 quarterly earnings.

BUY

Starting to deliver on the earnings growth. Earnings should be up about 17% this year and 18% next year.

Showing 526 to 540 of 718 entries

Most Recent Experts

Stan Wong

Private Wealth Management, ScotiaMcleod

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Chris Blumas

at Raymond James Investment Counsel Ltd.

Shannon Saccocia, CIO, Boston Private

Boston Private

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Thomson Reuters Corp (TRI.TO)